TM / path Flashcards
PRBC: preparation, storage temp, storage duration
centrifuge whole blood and filter (leukoreduction, remove plt)
2-6C storage
35 d
plt: preparation, storage temp, storage duration
apheresis
pooled: 4 donors; whole blood buffy coat + filter leukoreduction
20-24C (room temp) w constant gentle agitation
5-7d
FFP : preparation, storage temp, storage duration
apheresis
whole blood centrifugation
- FFP means frozen <8h from collection
< -18C, 2-6C once thawed
1y
5d thawed
28d never frozen
Cryo: preparation, storage temp, storage duration
insoluble precipitate on centrifugation of FFP
< -18C
1y
plasma derived product preparation
pooled samples from cold ethanol fractionation
Cryo includes:
Fibrinogen, VIII, XIII, VWF
examples of plasma derived products
IVIG
albumin
PCC
rhogam
coagulation factors
IVIG indications
ITP, NAIT, HDNF
primary immunodeficiency
secondary immunodeficiency (hypogamm, post ritux, post BMT)
Kawasaki
HIV
neuro: GBS, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, myasthenia gravis
IVIG S/E
common: rash, h/a, flushing, arthralgia, mild temp increase, tachypnea/tachycardia
severe: hypotension, fever/chill/rigor, bronchospasm, allergy/anaphylaxis, rare aseptic meningitis
Post: neutropenia, hemolytic anemia (10%), h/a, fluid overload, thrombus (1%)
Dose and expected rise with PRBC, plt, FFP, cryo
PRBC: 15 cc/kg - 20 point rise
plt: 10 cc/kg - 30-50 point rise
FFP: 10-20 cc/kg - increase of 30-50%
cryo: 1 U/10kg to max 10 U - fibrinogen increase by 0.5 g/L
FFP indications
TTP
INR >1.8, PTT > 1.5x ULN
MTP
PLEX replacement fluid
factor deficiency replacement (no specific product available)
warfarin reversal (if PCC unavailable)
Cryo indications
Riastap preferred!
APL
DIC
MTP
hypofibrinogenemia
leukoreduction benefits
reduced TA-GVHD
reduced FNHTR
reduced HLA alloimmunization
reduced CMV
PRBC irradiation pro/con, indications
Pro: reduces TA-GVHD risk (by removing T cells)
Con: shortens shelf life, may increase K
IUT
immunocompromised
directed donation
post BMT/some chemo, malignancy (HL)
neonates <1yo
when/how to cryopreserve PRBC
rare blood donor program
< -65C in glycerol
lasts 10y
which viruses not destroyed by viral inactivation
parvovirus
hepatitis A
development of RBC Ag/Ab
Glycotransferases add A or B Ag to H Ag (fucose) base chain
lack of H = Bombay
anti-A and -B Ab are formed early in life from exposure to similar appearing Ag
Bombay phenotype is
lack of H (fucose) base chain
Describe forward vs reverse typing
forward: pt RBC + anti_ reagant (testing for pt Ag)
reverse: pt plasma + test RBCs (testing for pt Ab)
blood group incidence (including Rh)
O 45%
A 40%
B 10%
AB 5%
Rh+ 85%
forward/reverse typing inconsistency reasons
lab error
immunosuppression
young infants
ABO-mismatch HSCT
chimerism
extra reverse typing: recent non-matched transfusion, autoAb, Rouleaux
missing reverse: infant, immunosuppression
standard vs extended vs full phenotype matching
Standard: Rh (DCE), K
Extended: Rh, K, Jka, Jkb, Fya, Fyb
Full: Ss
Most immunogenic RBC Ag
D (50%) > K (5%) > c > E > k > e …
risk with directed donations
increased:
- TA-TMA
- infection
- cost/waste